Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature.

Schillie SF, Spradling PR, Murphy TV.

Diabetes Care. 2012 Dec;35(12):2690-7. doi: 10.2337/dc12-0312. Review. No abstract available.

2.

Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients.

Fabrizi F, Dixit V, Martin P, Messa P.

Aliment Pharmacol Ther. 2011 Apr;33(7):815-21. doi: 10.1111/j.1365-2036.2011.04589.x. Epub 2011 Feb 1.

3.

Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.

Douvin C, Simon D, Charles MA, Deforges L, Bierling P, Lehner V, Budkowska A, Dhumeaux D.

Diabetes Care. 1997 Feb;20(2):148-51.

PMID:
9118762
4.

Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients.

Fabrizi F, Dixit V, Messa P, Martin P.

Aliment Pharmacol Ther. 2010 Sep;32(6):756-62. doi: 10.1111/j.1365-2036.2010.04410.x. Epub 2010 Jul 20.

5.

The evaluation of immune responses to hepatitis B vaccination in diabetic and non-diabetic haemodialysis patients and the use of tetanus toxoid.

Ocak S, Eskiocak AF.

Nephrology (Carlton). 2008 Dec;13(6):487-91. doi: 10.1111/j.1440-1797.2008.00936.x. Epub 2008 Mar 5.

PMID:
18331434
6.

Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.

Fabrizi F, Dixit V, Messa P, Martin P.

Vaccine. 2012 Mar 16;30(13):2295-300. doi: 10.1016/j.vaccine.2012.01.064. Epub 2012 Jan 26.

PMID:
22285268
7.

Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease.

Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G.

Aliment Pharmacol Ther. 2004 Nov 15;20(10):1053-62.

8.

Hepatitis B vaccine recombinant (Janssen/Medeva). Hepagene.

[No authors listed]

Drugs R D. 1999 Sep;2(3):201-2. No abstract available.

PMID:
10641227
9.

Hepatitis B vaccine recombinant (bio-technology general). BioHepB, Sci-B-Vac.

[No authors listed]

Drugs R D. 1999 Sep;2(3):199-200. No abstract available.

PMID:
10641226
10.

Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents.

Elrashidy H, Elbahrawy A, El-Didamony G, Mostafa M, George NM, Elwassief A, Saeid Mohamed AG, Elmestikawy A, Morsy MH, Hashim A, Abdelbasseer MA.

Hum Vaccin Immunother. 2013 Sep;9(9):2002-6. doi: 10.4161/hv.25426. Epub 2013 Jun 20.

11.

Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine.

Zhang W, Han L, Lin C, Wang H, Pang X, Li L, Gao P, Lin H, Gong X, Tang Y, Ma J, Zhang H, Wang C, Yang P, Li H, Sun M, He X.

Vaccine. 2011 Aug 26;29(37):6276-82. doi: 10.1016/j.vaccine.2011.06.045. Epub 2011 Jun 29.

PMID:
21722684
12.

Hepatitis B virus vaccine in chronic kidney diseases: improved immunogenicity by adjuvants? Limits of a meta-analysis.

Di Pasquale A, De Ridder M, Van Der Meeren O.

Vaccine. 2012 Aug 17;30(38):5586. doi: 10.1016/j.vaccine.2012.06.023. Epub 2012 Jun 27. No abstract available.

PMID:
22749597
13.

Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.

Wu Q, Zhuang GH, Wang XL, Wang LR, Li N, Zhang M.

Vaccine. 2011 Mar 9;29(12):2302-7. doi: 10.1016/j.vaccine.2011.01.025. Epub 2011 Jan 28.

PMID:
21277403
14.
15.

Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review.

Schillie SF, Murphy TV.

Vaccine. 2013 May 17;31(21):2506-16. doi: 10.1016/j.vaccine.2012.12.012. Epub 2012 Dec 17. Review.

PMID:
23257713
16.

Hepatitis B vaccination for patients with chronic renal failure.

Schroth RJ, Hitchon CA, Uhanova J, Noreddin A, Taback SP, Moffatt ME, Zacharias JM.

Cochrane Database Syst Rev. 2004;(3):CD003775. Review.

PMID:
15266500
17.

Reduced immune response to hepatitis B vaccine in children with insulin dependent diabetes.

Fiçicioğlu C, Mikla S, Midilli K, Aydin A, Cam H, Erğin S.

Acta Paediatr Jpn. 1995 Dec;37(6):687-90.

PMID:
8775551
18.

Successful immune response to a recombinant hepatitis B vaccine in young patients with insulin-dependent diabetes mellitus.

Marseglia GL, Scaramuzza A, d'Annunzio G, Comolli G, Gatti M, Lorini R.

Diabet Med. 1996 Jul;13(7):630-3.

PMID:
8840096
19.

Loss of antibodies, but not of protection.

Wenzel JJ, Jilg W.

Lancet Infect Dis. 2010 Nov;10(11):738-9. doi: 10.1016/S1473-3099(10)70217-6. No abstract available.

PMID:
21029981
20.

Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination: a meta-analysis.

Cruciani M, Mengoli C, Serpelloni G, Mazzi R, Bosco O, Malena M.

Vaccine. 2007 Jan 8;25(4):709-18. Epub 2006 Aug 22.

PMID:
16963165

Supplemental Content

Support Center